The common molecular feature found in dystroglycanopathy is a deficiency in the glycosylation of dystroglycan, which diminishes the ligand-binding activity of this glycoprotein1, 2. The gene discussed is DAG1; the disease is neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.